About Eslicarbazepine Acetate API
Therapeutic CategoryCentral Nervous System (CNS)
CAS Number
236395-14-5
API Technology
Synthetic
Dose Form
Oral Solid/Tablets
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, EUDMF
Mechanism of Action
APTIOM is extensively converted to eslicarbazepine, which is considered to be responsible for therapeutic effects in humans. The precise mechanism(s) by which eslicarbazepine exerts anticonvulsant activity is unknown but is thought to involve inhibition of voltage-gated sodium channels.
Indication
APTIOM is indicated for the treatment of partial-onset seizures in patients 4 years of age and older.
Related APIs
Eslicarbazepine Acetate-es
Central Nervous System (CNS)
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!